Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...
Following the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.
Investing News Network on MSN8 小时
5 Best-performing Canadian Pharma Stocks of 2025
From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...
THE WEEK’S MOST POPULAR SONGS RANKED BY ADULT ALTERNATIVE RADIO AIRPLAY DETECTIONS, AS MEASURED BY MEDIABASE AND PROVIDED BY LUMINATE. STATIONS ARE ELECTRONICALLY MONITORED 24 HOURS A DAY ...
Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.